Trials
Search / Trial NCT06421051

Transauricular Vagus Nerve Stimulation Improves Postoperative Sleep Disorders in Elderly Patients.

Launched by BEIJING TIANTAN HOSPITAL · May 15, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transauricular vagus nerve stimulation to help improve sleep problems in older patients after they have surgery. Many elderly patients experience difficulty sleeping after going under general anesthesia, which can lead to issues like memory problems and increased pain. The goal of this study is to see if this new treatment can help these patients sleep better, ultimately improving their overall recovery and health.

To be eligible for this trial, participants need to be at least 65 years old and scheduled for certain types of surgery that do not involve the brain. They also need to be able to sign a consent form to participate. During the study, participants will receive either the treatment or a placebo (a non-active treatment), and neither they nor the doctors will know which one they are getting. This helps ensure that the results are fair and reliable. If you or someone you know fits these criteria and is interested in participating, it could be an important opportunity to contribute to research that may improve postoperative care for older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing non-craniocerebral surgery under elective general anesthesia
  • Age ≥65 years old
  • American society of Aneshesiologists Grade I to III
  • Sign informed consent
  • Exclusion Criteria:
  • Patients who are expected to retain tracheal intubation after surgery
  • Disturbance of consciousness, mental disorder, inability to cooperate
  • Expected survival \< 3 months
  • The estimated operation time is \< 2 hours
  • The expected postoperative hospital stay is \< 5 days

About Beijing Tiantan Hospital

Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.

Locations

Beijing, Beijing, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0